Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.
about
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisUnfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisUnfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisInflammatory bowel disease and thromboembolismHaemostatic system in inflammatory bowel diseases: new players in gut inflammation.Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory ResponsesThrombin mediates the extraintestinal thrombosis associated with experimental colitis.Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention.The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials.Cerebral sinus venous thrombosis in inflammatory bowel diseases.Prevention of venous thromboembolism in hospitalized patients with inflammatory bowel disease.Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes.Managing acute severe ulcerative colitis in the hosptialised setting.Rivaroxaban Induces Mucosal Healing in a Rat Model of Trinitrobenzene Sulfonic Acid-Induced Colitis.Leukocytapheresis in ulcerative colitis: a possible alternative to biological therapy?Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.
P2860
Q24188013-B80A7250-F74C-4CD8-A181-5D71E9AAFFDCQ24234403-F7F23291-626F-4B2D-95BD-161F4FF050FFQ24243052-49D0B66D-4FA7-4EF0-80CE-F15CA1436CE8Q34326640-6D87E8E6-09FF-448F-8C33-68CAAD1B3961Q34579752-D4742F74-EDD4-4B9F-9256-5C60FAB02CA6Q35719599-11D7FE19-DD4C-4E69-93FD-5EFF90E5E6BCQ36977023-2ADA1BC2-8414-4735-9901-269ECE626BC5Q37789688-B8E7FE4B-EA28-4E61-9D9A-15CB28B65421Q37808230-9DA89C15-3ACB-4940-ACE8-6873D19AF0B9Q37880700-EC23732C-7C6A-4D7F-86E1-13FB9DE62D1FQ38067699-B0F0EC79-0B5A-426D-A662-FAB0BE9019D3Q38079397-F200F301-5493-4FC8-BCDE-03A6D4883335Q38574126-86FA9FE8-510B-4F27-BD62-EEAF297F684FQ42116204-7A220B51-B3ED-428A-AB50-B7E65AE2EC15Q42756560-B17A6800-865B-44DE-A0CE-0AAC13A8530CQ43247779-F045D0B4-659D-4BF7-9470-3A450FDD94F2Q55262670-F3D72077-0526-4CC3-8703-6D7DD866B70F
P2860
Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Randomized, placebo-controlled ...... in active ulcerative colitis.
@en
Randomized, placebo-controlled ...... in active ulcerative colitis.
@nl
type
label
Randomized, placebo-controlled ...... in active ulcerative colitis.
@en
Randomized, placebo-controlled ...... in active ulcerative colitis.
@nl
prefLabel
Randomized, placebo-controlled ...... in active ulcerative colitis.
@en
Randomized, placebo-controlled ...... in active ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Randomized, placebo-controlled ...... n in active ulcerative colitis
@en
P2093
A E de Jong
A H Oberndorff-Klein Woolthuis
E J Schoon
G Dijkstra
M A de Bièvre
R W Stockbrügger
P2860
P304
P356
10.1002/IBD.20085
P50
P577
2007-06-01T00:00:00Z